Evaluation of iNstroke Aspiration Catheters for Thrombectomy: a Multi-center Prospective Study

Exclusion Criteria

• •1. Severe comorbidity and/or shortened life expectancy that will likely prevent improvement or follow up or that will render the procedure unlikely to benefit the patient.
• •2. Severe allergy to contrast media.
• •3. As applicable by French laws: breastfeeding women, persons deprived of their liberty by a judicial or administrative decision, or persons of full age who are the subject of a legal protection measure.
• •4. Patients with intracranial atherosclerotic occlusive disease or extra- or intracranial dissection.
• •5. Multiple Intracranial Occlusions
• •6. Known medical history of thrombocytopenia (Platelets \<100,000).
• •7. Presence of intracerebral hemorrhage.
• •8. Significant mass effect and/or midline shift.
• •9. Evidence of intracranial tumor (except small meningioma).
• •10. Intracranial stenosis proximal to the occlusion.
• •11. Severe sustained hypertension (systolic pressure \>185 mm Hg or diastolic pressure \>110 mm Hg). Note: If blood pressure can be successfully reduced and maintained at an acceptable level by administering the medication recommended by the ESO (European Stroke Organisation) in its guidelines (also IV infusion of antihypertensives), the patient may be included.
• •12. Known or suspected cerebral vasculitis.
• •13. Known renal insufficiency with creatinine ≥3 mg/dl or Glomerular Filtration Rate (GFR) \<30 mL/min.
• •14. Current participation in an interventional drug or device study that may confound the results of this study.